R. Ballester

532 total citations
19 papers, 390 citations indexed

About

R. Ballester is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, R. Ballester has authored 19 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Cancer Research and 5 papers in Genetics. Recurrent topics in R. Ballester's work include Glioma Diagnosis and Treatment (5 papers), Brain Metastases and Treatment (3 papers) and Cancer Genomics and Diagnostics (3 papers). R. Ballester is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Brain Metastases and Treatment (3 papers) and Cancer Genomics and Diagnostics (3 papers). R. Ballester collaborates with scholars based in Spain, France and United Kingdom. R. Ballester's co-authors include Carmen Balañá, Rafael Rosell, Salvador Lluch, Pascual Medina, Gloria Segarra, Pedro Méndez, Miquel Tarón, Carme Sarries, José Javier Sánchez and José Luis Ramírez and has published in prestigious journals such as Stroke, European Journal of Cancer and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

R. Ballester

19 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Ballester Spain 12 148 130 95 76 51 19 390
Yufang Zhu China 13 117 0.8× 162 1.2× 131 1.4× 73 1.0× 21 0.4× 41 518
Lisbeth Ärlestig Sweden 18 63 0.4× 158 1.2× 40 0.4× 51 0.7× 43 0.8× 31 721
Yu Jin China 11 172 1.2× 67 0.5× 36 0.4× 37 0.5× 38 0.7× 34 454
Patricia Kuiper Netherlands 8 49 0.3× 132 1.0× 65 0.7× 42 0.6× 18 0.4× 12 430
Timo Z. Nazari‐Shafti Germany 12 62 0.4× 166 1.3× 65 0.7× 51 0.7× 46 0.9× 31 419
Doiniţa Crişan Romania 12 33 0.2× 96 0.7× 53 0.6× 78 1.0× 38 0.7× 51 398
Enrique López‐Aguilar Mexico 11 160 1.1× 181 1.4× 109 1.1× 60 0.8× 36 0.7× 25 457
L Dunlop Australia 10 39 0.3× 125 1.0× 59 0.6× 40 0.5× 30 0.6× 17 630
Akira Takao Japan 10 42 0.3× 176 1.4× 54 0.6× 36 0.5× 34 0.7× 22 435
Huasong Feng China 10 54 0.4× 123 0.9× 36 0.4× 222 2.9× 13 0.3× 12 436

Countries citing papers authored by R. Ballester

Since Specialization
Citations

This map shows the geographic impact of R. Ballester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Ballester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Ballester more than expected).

Fields of papers citing papers by R. Ballester

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Ballester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Ballester. The network helps show where R. Ballester may publish in the future.

Co-authorship network of co-authors of R. Ballester

This figure shows the co-authorship network connecting the top 25 collaborators of R. Ballester. A scholar is included among the top collaborators of R. Ballester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Ballester. R. Ballester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Llamas‐Velasco, Mar, et al.. (2023). Approach to the so-called “Invisible Dermatosis”: When Subtle Histopathological Findings Guide Diagnosis. American Journal of Dermatopathology. 45(12). 801–811. 1 indexed citations
2.
Mollà, Meritxell, Meritxell Arenas, E. Martinez, et al.. (2022). Evidence-based guidelines for hypofractionated radiation in breast cancer: conclusions of the Catalan expert working group. Clinical & Translational Oncology. 24(8). 1580–1587. 5 indexed citations
3.
Cirauqui, Beatriz, Teresa Morán, Anna Estival, et al.. (2020). Breast Cancer Patient with Li-Fraumeni Syndrome: A Case Report Highlighting the Importance of Multidisciplinary Management. Case Reports in Oncology. 13(1). 130–138. 2 indexed citations
4.
Hernández, Vanessa, Núria Baixeras, Daniel Cuadras, et al.. (2017). Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to Prophylaxis. Frontiers in Oncology. 7. 283–283. 11 indexed citations
5.
Farrús, B., F. Moreno, Meritxell Arenas, et al.. (2017). Management of breast ductal carcinoma in situ in Catalonia, Spain: Results from the Grup Oncologic Calalà-Occità-Catalonia survey with 9-year follow up. The Breast. 35. 196–202. 4 indexed citations
6.
Hernández, Vanessa, Emre Güney, Laia Muixí, et al.. (2015). FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies. Oncotarget. 6(42). 44254–44273. 27 indexed citations
7.
Gane, Edward, Paul J. Pockros, Stefan Zeuzem, et al.. (2014). Mericitabine and ritonavir‐boosted danoprevir with or without ribavirin in treatment‐naive HCV genotype 1 patients: INFORM ‐ SVR study. Liver International. 35(1). 79–89. 23 indexed citations
8.
Balañá, Carmen, Jaume Capellades, Pilar Teixidor, et al.. (2007). Clinical course of high-grade glioma patients with a “biopsy-only” surgical approach: a need for individualised treatment. Clinical & Translational Oncology. 9(12). 797–803. 21 indexed citations
9.
Balañá, Carmen, et al.. (2007). Medulloblastoma in young adults. Must we give adjuvant chemotherapy?. Clinical & Translational Oncology. 9(2). 121–123. 3 indexed citations
10.
Ballester, R., et al.. (2007). El análisis modal de fallos y efectos (AMFE) ayuda a aumentar la seguridad en radioterapia. Revista de Calidad Asistencial. 22(6). 299–309. 11 indexed citations
11.
12.
Balañá, Carmen, José Luis Ramírez, Miquel Tarón, et al.. (2003). O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.. PubMed. 9(4). 1461–8. 124 indexed citations
13.
Balañá, Carmen, M. Fraile, Jaume Capellades, et al.. (2002). Use of 201Tl SPECT Imaging to Assess the Response to Therapy in Patients with High Grade Gliomas. Journal of Neuro-Oncology. 59(1). 81–90. 16 indexed citations
14.
Segarra, Gloria, Pascual Medina, José María Vila, et al.. (2000). Contractile effects of arginine analogues on human internal thoracic and radial arteries. Journal of Thoracic and Cardiovascular Surgery. 120(4). 729–736. 11 indexed citations
15.
Medina, Pascual, Gloria Segarra, R. Ballester, et al.. (2000). Effects of antidepressants in adrenergic neurotransmission of human vas deferens. Urology. 55(4). 592–597. 22 indexed citations
16.
Segarra, Gloria, Pascual Medina, R. Ballester, et al.. (1999). Effects of Some Guanidino Compounds on Human Cerebral Arteries. Stroke. 30(10). 2206–2211. 62 indexed citations
17.
Ballester, R., et al.. (1995). 432 Matching half beams in head and neck radiotherapy. planning and dosimetry. European Journal of Cancer. 31. S93–S93. 1 indexed citations
18.
Miziak, Barbara, et al.. (1988). Comparison of the cutaneous/systemic antiinflammatory activity ratios for desonide and hydrocortisone in various experimental models.. PubMed. 38(4). 542–5. 3 indexed citations
19.
Miziak, Barbara, et al.. (1987). Cutaneously applied erythromycin base reduces various types of inflammatory reactions in mouse ear.. PubMed. 9(1). 77–85. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yufang Zhu Breakdown of academic impact, for papers by Lisbeth Ärlestig Breakdown of academic impact, for papers by Yu Jin Breakdown of academic impact, for papers by Patricia Kuiper Breakdown of academic impact, for papers by Timo Z. Nazari‐Shafti Breakdown of academic impact, for papers by Doiniţa Crişan Breakdown of academic impact, for papers by Enrique López‐Aguilar Breakdown of academic impact, for papers by L Dunlop Breakdown of academic impact, for papers by Akira Takao Breakdown of academic impact, for papers by Huasong Feng
Rankless by CCL
2026